Global Reach & Impact
Fast-growing pharmaceutical company covering Greater China, Southeast Asia (SEA), Middle East(ME).
$1.4 Bn
Revenue
$400 Mn
Net Profit
$120 Mn
R&D Investment
6000+
Employees
Full value chain capabilities from development, registration, manufacture, supply, to commercialization of global innovative products in complex emerging markets.
Evolution & Global Leadership
Sustained growth powered by our evolving strategy:
China exclusive distributor for originator products from global pharma
1992-2010
Acquire mature brands from global pharma and local pharma
2011-2018
Transition towards innovation
2018 onwards
Committed to invest in R&D, with global vision
2023-2025
APAC focused global pharma, with full value chain capabilities from R&D, manufacture, to commercialization
2026 onwards